Directory of Drugs: Angiomax - Bivalirudin
Brand Name: Angiomax
What is Angiomax used for?
Angiomax is used:
· to reduce the risk of blood clotting in adults with severe chest pain (unstable angina) who are undergoing a procedure to open blocked arteries in the heart (percutaneous transluminal coronary angioplasty or PCTA).
· to reduce the risk of blood clotting in adults who are undergoing a procedure to open blocked arteries in the heart (percutaneous coronary intervention or PCI). Angiomax may be given with glycoprotein IIb/IIIa inhibitor under some circumstances in patients undergoing PCI.
· to reduce the risk of blood clotting in adults with, or at risk of, heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) undergoing PCI.
Angiomax is given by intravenous injection in addition to aspirin during treatment.
The safety and effectiveness of Angiomax is not known in patients who are not undergoing PCTA or PCI or in patients who have other heart problems. Angiomax has also not been tested in combination with blood thinners other than aspirin.
Who should not be given Angiomax?
Angiomax should not be given to individuals who currently have major bleeding.
What should I tell my doctor or healthcare provider?
Because of the potential for increased bleeding with aspirin and Angiomax, tell your doctor or healthcare provider if you:
Because certain other medications can increase the risk of bleeding with Angiomax, review all medications that you are taking with your healthcare provider, including those that you take without a prescription. Tell your doctor or healthcare provider if you are taking:
What are some possible side effects of Angiomax? (This is NOT a complete list of side effects reported with Angiomax. Your doctor can discuss with you a more complete list of side effects.)
The most common side effect of Angiomax is bleeding.
Other side effects include:
Date created: June 18, 2001, updated: April 19, 2006
© 2007 Directory of Drugs - reference guide to drugs - All rights reserved - Legal Notice